COMP <GO>
CLOV vs ACHC // PIOTROSKI F-SCORE QUALITY
Clover Health Investments Corp. (Class A) (NASDAQ) VS. Acadia Healthcare Company Inc. (NASDAQ) • 15-METRIC TALLY: CLOV 5
— ACHC 4
▲ PIOTROSKI F-SCORE QUALITY LEADER: ACHC
LAST: $4.46 (-2.62%) • MKT CAP: $2.37B
piotroski-score
3/9
LAST: $29.96 (+1.70%) • MKT CAP: $2.79B
piotroski-score
5/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLOV VS. ACHC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLOV | ACHC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -29.30% | -24.80% | -4.50 | ACHC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.84% | -16.04% | +13.20 | CLOV | /fcf-yield <GO> |
| Operating Margin | -4.40% | -40.60% | +36.20 | CLOV | /operating-margins <GO> |
| Net Profit Margin | -4.40% | -33.30% | +28.90 | CLOV | /net-margins <GO> |
| Revenue Growth (YoY) | 40.30% | 5.00% | +35.30 | CLOV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.62 | 0.45 | +3.17 | CLOV | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 3/9 | 5/9 | -2.00 | ACHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.7 | 50.9 | -5.20 | ACHC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.07 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 21.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.37B | $2.79B | -$420.3M | ACHC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLOV REV | ACHC REV | CLOV GROSS % | ACHC GROSS % | CLOV FCF | ACHC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.92B | $3.31B | — | — | -$69.0M | -$439.9M |
| FY 2024 | $1.37B | $3.15B | — | — | $33.3M | -$560.7M |
| FY 2023 | $1.26B | $2.93B | — | — | -$144.7M | $330.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLOV // BETA —
ACHC // BETA 1.07